Viewing Study NCT01636557


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT01636557
Status: COMPLETED
Last Update Posted: 2017-03-07
First Post: 2012-07-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Rheumatoid View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid arthritis View
None sirukumab View
None CNTO 136 View
None CYP450 enzyme View
None anti-interleukin-6 monoclonal antibody View